Empire Life Investments Inc. Arcturus Therapeutics Holdings Inc. Transaction History
Empire Life Investments Inc.
- $1.65 Billion
- Q3 2025
A detailed history of Empire Life Investments Inc. transactions in Arcturus Therapeutics Holdings Inc. stock. As of the latest transaction made, Empire Life Investments Inc. holds 417,563 shares of ARCT stock, worth $3.04 Million. This represents 0.47% of its overall portfolio holdings.
Number of Shares
417,563
Previous 264,012
58.16%
Holding current value
$3.04 Million
Previous $3.43 Million
124.08%
% of portfolio
0.47%
Previous 0.23%
Shares
5 transactions
Others Institutions Holding ARCT
# of Institutions
173Shares Held
26MCall Options Held
2.32MPut Options Held
866K-
Federated Hermes, Inc. Pittsburgh, PA4.69MShares$34.1 Million0.16% of portfolio
-
Black Rock Inc. New York, NY2.65MShares$19.3 Million0.0% of portfolio
-
Nikko Asset Management Americas, Inc.1.95MShares$14.2 Million0.39% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.1.95MShares$14.2 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.89MShares$13.7 Million0.0% of portfolio
About Arcturus Therapeutics Holdings Inc.
- Ticker ARCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,576,400
- Market Cap $193M
- Description
- Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...